128 related items for PubMed ID: 24858152
1. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
Mymensingh Med J; 2014 Apr; 23(2):261-7. PubMed ID: 24858152
[Abstract] [Full Text] [Related]
2. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, Bonilla-Felix M, Nash M, Roy S, Strife CF, Arbus G.
Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959
[Abstract] [Full Text] [Related]
3. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
4. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov 23; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
5. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Nov 23; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
6. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan 23; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
7. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 23; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
8. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
Kidney Int; 2000 Sep 23; 58(3):1247-52. PubMed ID: 10972687
[Abstract] [Full Text] [Related]
9. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children.
Am J Kidney Dis; 2003 Jun 23; 41(6):1155-62. PubMed ID: 12776266
[Abstract] [Full Text] [Related]
10. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct 23; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
11. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T.
J Pediatr; 1988 Jan 23; 112(1):122-6. PubMed ID: 3335948
[Abstract] [Full Text] [Related]
12. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
13. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug 08; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
14. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
Nihon Jinzo Gakkai Shi; 2010 Aug 08; 52(8):1029-36. PubMed ID: 21254699
[Abstract] [Full Text] [Related]
15. A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center.
Al Talhi A, Al Saran K, Osman ET, Al Shatri A, Osman M, Mirza K.
Int J Pediatr Adolesc Med; 2018 Mar 08; 5(1):18-23. PubMed ID: 30805527
[Abstract] [Full Text] [Related]
16. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
Simmonds J, Grundy N, Trompeter R, Tullus K.
Arch Dis Child; 2010 Feb 08; 95(2):146-9. PubMed ID: 20172895
[Abstract] [Full Text] [Related]
17. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P, Jesdapatarakul S.
J Med Assoc Thai; 2000 Mar 08; 83(3):315-24. PubMed ID: 10808687
[Abstract] [Full Text] [Related]
18. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS, Trompeter RS.
Arch Dis Child; 2008 Mar 08; 93(3):226-8. PubMed ID: 17573408
[Abstract] [Full Text] [Related]
19. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul 08; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
20. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V, Krishnamurthy S, Harichandrakumar KT.
Pediatr Nephrol; 2016 Apr 08; 31(4):595-604. PubMed ID: 26759000
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
